ReviewCancer drug resistance (Alhambra, Calif.)2024

HER3-targeted therapy: the mechanism of drug resistance and the development of anticancer drugs.

Huilan Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.